1-3 of 3
Jo-Anne Young
Close
Sort by
Journal Articles

Final Outcomes from a Phase 2 Trial of Posoleucel in Allogeneic Hematopoietic Cell Transplant Recipients

Clinical Trials & Observations
Sanjeet Singh Dadwal, Rajat Bansal, Michael Schuster, Jean A. Yared, Gary Douglas Myers, Michelle Elizabeth Matzko, Sama Adnan, David McNeel, Julie Ma, Sarah A Gilmore, Spyridoula Vasileiou, Ann M Leen, Joshua A Hill, Jo-Anne Young
Journal: Blood Advances
Blood Adv bloodadvances.2023011562.
https://doi.org/10.1182/bloodadvances.2023011562
Published: 2024
Includes: Supplemental data
Journal Articles

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes

Shannon Herzog, Daniel J. Weisdorf, Ryan Shanley, Ahmad Rayes, Shernan G. Holtan, Jo-Anne Young, Margaret L. MacMillan, Najla El Jurdi
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3644–3650.
https://doi.org/10.1182/bloodadvances.2022009505
Published: 2023
Includes: Supplemental data
Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Clinical Trials & Observations
Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1352–1359.
https://doi.org/10.1182/bloodadvances.2020003937
Published: 2021
Includes: Supplemental data